- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Gli1/DNA interaction is a druggable target for Hedgehog‐dependent tumors ; volume:34 ; number:2 ; year:2015 ; pages:200-217 ; extent:18
The EMBO journal / European Molecular Biology Organization ; 34, Heft 2 (2015), 200-217 (gesamt 18)
- Urheber
-
Infante, Paola
Mori, Mattia
Alfonsi, Romina
Ghirga, Francesca
Aiello, Federica
Toscano, Sara
Ingallina, Cinzia
Siler, Mariangela
Cucchi, Danilo
Po, Agnese
Miele, Evelina
D'Amico, Davide
Canettieri, Gianluca
De Smaele, Enrico
Ferretti, Elisabetta
Screpanti, Isabella
Uccello Barretta, Gloria
Botta, Maurizio
Botta, Bruno
Gulino, Alberto
Di Marcotullio, Lucia
- DOI
-
10.15252/embj.201489213
- URN
-
urn:nbn:de:101:1-2022112507040243563533
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Infante, Paola
- Mori, Mattia
- Alfonsi, Romina
- Ghirga, Francesca
- Aiello, Federica
- Toscano, Sara
- Ingallina, Cinzia
- Siler, Mariangela
- Cucchi, Danilo
- Po, Agnese
- Miele, Evelina
- D'Amico, Davide
- Canettieri, Gianluca
- De Smaele, Enrico
- Ferretti, Elisabetta
- Screpanti, Isabella
- Uccello Barretta, Gloria
- Botta, Maurizio
- Botta, Bruno
- Gulino, Alberto
- Di Marcotullio, Lucia
Ähnliche Objekte (12)
Cysteine metabolic circuitries: druggable targets in cancer
Network analysis of atherosclerotic genes elucidates druggable targets
In search of druggable targets for GBM amino acid metabolism
NMNAT2 is a druggable target to drive neuronal NAD production
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
A Multiplex CRISPR‐Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production
Cysteine metabolic circuitries: druggable targets in cancer
Network analysis of atherosclerotic genes elucidates druggable targets
In search of druggable targets for GBM amino acid metabolism
NMNAT2 is a druggable target to drive neuronal NAD production
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
A Multiplex CRISPR‐Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production
Cysteine metabolic circuitries: druggable targets in cancer
Network analysis of atherosclerotic genes elucidates druggable targets
In search of druggable targets for GBM amino acid metabolism
NMNAT2 is a druggable target to drive neuronal NAD production
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
A Multiplex CRISPR‐Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum